N-alkylated 1,4-dihydropyridines: new agents to overcome multidrug resistance.

Abstract

New N-alkylated 1,4-dihydropyridine derivatives were synthesized and their ability to overcome multidrug resistance was examined in vincristine-resistant P388 cells (P388/VCR cells). Compounds that possessed an arylalkyl substituent on the dihydropyridine ring nitrogen were more potent than verapamil in potentiating the cytotoxicity of vincristine against P388/VCR cells. However, neither drug effectively enhanced the antitumor activity of vincristine in tumor-bearing mice. Introduction of basic nitrogen-containing substituents on the side chain of 1,4-dihydropyridines gave improved activity in vitro and in vivo. The piperazine derivative 12c and 12o were more than 10 times as potent as verapamil in vitro. Four compounds selected for in vivo testing showed superior antitumor activity in P388/VCR-bearing mice in combination with vincristine. The structure-activity relationships of the compounds are discussed.

Statistics

0200400600'97'99'01'03'05'07'09'11'13'15'17
Citations per Year

246 Citations

Semantic Scholar estimates that this publication has 246 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ohsumi1995Nalkylated1N, title={N-alkylated 1,4-dihydropyridines: new agents to overcome multidrug resistance.}, author={Koji Ohsumi and Kenji Ohishi and Yoshiko Morinaga and Reiko Nakagawa and Yasushi Suga and Takayuki Sekiyama and Yoshinori Akiyama and Takao Tsuji and Takashi Tsuruo}, journal={Chemical & pharmaceutical bulletin}, year={1995}, volume={43 5}, pages={818-28} }